Richard M. Marsh, V.P, General Counsel at MYRIAD GENETICS INC (MYGN), sold 17,204 shares at $75.06 ($871K) on 2009-01-29, disclosed to the SEC on 2009-01-30.
Scheduled sale ($871k) by V.P, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,600 | $0 | 0.0% |
| 2 | $0.00 | 2,000 | $0 | 0.0% |
| 3 | $0.00 | 2,000 | $0 | 0.0% |
| 4 | $75.06 | 1,800 | $135K | 15.5% |
| 5 | $75.03 | 9,804 | $736K | 84.5% |
| Total | $50.61 avg | 17,204 |
| $871K |
| 100% |
| Filing → |
| MYGN | SELL | 2018-06-01 | $1.3M | — | Filing → |
| MYGN | SELL | 2018-01-22 | $3.0M | — | Filing → |
| MYGN | SELL | 2018-01-19 | $1.5M | — | Filing → |